Currency: CNY
Period
Q1 FY2024 Earnings
--
1.58B
0.03
Strong Buy
May 15, 2024
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Guizhou Xinbang Pharmaceutical: 2024 First Quarter Report
Apr 29 00:00
Xinbang Pharmaceuticals: 2023 Annual Report
Apr 16 00:00
Xinbang Pharmaceuticals: 2023 Annual Report Summary
Xinbang Pharmaceutical: Report for the third quarter of 2023
Oct 30, 2023 00:00
Read more
Updated: May 15, 2024
Buy
Hold
Underperform
Sell
No Data